Shares of Innocoll Holdings PLC (NASDAQ:INNL) have been assigned a consensus broker rating score of 0.00 () from the five analysts that cover the company, Zacks Investment Research reports. Three investment analysts have rated the stock with a hold rating and two have assigned a strong buy rating to the company.
Analysts have set a one year consensus price objective of $4.50 for the company, according to Zacks. Zacks has also assigned Innocoll Holdings PLC an industry rank of 96 out of 265 based on the ratings given to related companies.
A number of brokerages have commented on INNL. Stifel Nicolaus cut shares of Innocoll Holdings PLC from a “buy” rating to a “hold” rating and reduced their price target for the company from $9.00 to $2.00 in a research report on Friday. FBR & Co cut shares of Innocoll Holdings PLC from an “outperform” rating to a “market perform” rating and increased their price target for the company from $2.00 to $10.00 in a research report on Friday, December 30th. Zacks Investment Research cut shares of Innocoll Holdings PLC from a “buy” rating to a “hold” rating in a research report on Wednesday, March 1st. JMP Securities cut shares of Innocoll Holdings PLC from an “outperform” rating to a “market perform” rating in a research report on Friday, December 30th. Finally, Janney Montgomery Scott cut shares of Innocoll Holdings PLC from a “buy” rating to a “neutral” rating and set a $2.00 price target on the stock. in a research report on Friday, December 30th.
Your IP Address:
Shares of Innocoll Holdings PLC (NASDAQ:INNL) opened at 1.12 on Tuesday. The stock has a 50 day moving average of $0.78 and a 200 day moving average of $2.97. The company’s market cap is $33.26 million. Innocoll Holdings PLC has a 1-year low of $0.53 and a 1-year high of $12.94.
A hedge fund recently raised its stake in Innocoll Holdings PLC stock. Alyeska Investment Group L.P. increased its position in shares of Innocoll Holdings PLC (NASDAQ:INNL) by 57.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 837,626 shares of the specialty pharmaceutical company’s stock after buying an additional 305,482 shares during the period. Alyeska Investment Group L.P. owned approximately 2.82% of Innocoll Holdings PLC worth $578,000 at the end of the most recent reporting period. 42.88% of the stock is currently owned by hedge funds and other institutional investors.
About Innocoll Holdings PLC
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.